Related Experiment Video
Updated: Sep 7, 2025
08:51
Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
Published on: February 19, 2021
9.2K
Clinical trials in multiple sclerosis: past, present, and future.
Navid Manouchehri1, Afsaneh Shirani2, Victor H Salinas1
1Department of Neurology, University of Texas Southwestern Medical Center, Dallas, TX, United States.
Neurologia I Neurochirurgia Polska
|June 17, 2022
Summary
Multiple sclerosis (MS) clinical trials have advanced significantly, leading to effective disease-modifying therapies (DMTs). Continued progress in diagnostics and biomarkers offers a roadmap for future MS interventions.
Area of Science:
- Neuroimmunology
- Clinical Trials
- Neuroscience
Background:
- Multiple sclerosis (MS) has been a major focus for clinical trial development over the past 40 years.
- Advances in neuroimmunology have yielded effective disease-modifying therapies (DMTs) for MS patients.
- Progress in diagnostic criteria, disability assessment, imaging, and biomarkers has enhanced MS management.
Purpose of the Study:
- To review the evolution of clinical trials in multiple sclerosis.
- To discuss the achievements in MS treatment and management.
- To identify opportunities for future improvements in MS clinical trials.
Main Methods:
- Review of historical clinical trial data in multiple sclerosis.
- Analysis of advancements in neuroimmunology and therapeutic development.
- Examination of diagnostic and assessment tools in MS.
Main Results:
- Significant progress in developing disease-modifying therapies (DMTs) for MS.
- Enhanced understanding of MS pathophysiology.
- Established clinical practices for MS diagnosis and management.
Conclusions:
- The evolution of MS clinical trials has led to substantial patient benefits.
- Current knowledge and practices provide a foundation for developing more targeted MS interventions.
- Opportunities exist to further refine MS clinical trials for improved outcomes.
Related Concept Videos
01:16Clinical Trials
7.4K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
7.4K
01:11Clinical Trials: Overview
3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K
01:15Myasthenia Gravis: Diagnostic Tests
1.3K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.3K